Table 3. Significance levels (p values) for (i) cervical precancer/cancer, (ii) progression to cervical precancer/cancer, and (iii) HPV persistence, among SNPs with p≤0.001 for an association with cervical precancer/cancer.

Gene	rs #	(i) CIN3/CA	(ii) CIN3/CA	(iii) HPV persistence
		vs. RC	vs. HPV persistence	Vs. RC
DMC1	RS5757133	0.0007	0.1590	0.1114
DUT	RS3784621	0.0004*	0.1280	0.0262
GTF2H4	RS2894054	0.0001*	0.8742	0.0002
GTF2H4	RS6926723	0.0004	0.6840	0.0034
IFNG	RS11177074	0.0003	0.0095	0.4011
OAS1	RS12307655	0.0005*	0.2790	0.0034
OAS2	RS718802	0.0001	0.1844	0.0057
OAS3	RS12302655	0.00008	0.1909	0.0025
POLN	RS17132382	0.0011	0.0103	0.5304
SULF1	RS4737999	0.0001*	0.8918	0.0020
SULF1	RS4284050	0.0007	0.4994	0.0020
SULF1	RS10108002	0.0010	0.5160	0.0181
TMC8,TMC6	RS9893818	0.0003	0.0019	0.8434

^*p<0.05 in oncogenic HPV+ restricted analyses.

SNP p values with FDR p<0.2 are denoted with astericks. Complete results for SNP-based results are shown in Supplemental Materials (Table S3 (SNPs listed in Table 2) and Table S4 (all)).